Variability in hospital treatment costs: a time-driven activity-based costing approach for early-stage invasive breast cancer patients

OBJECTIVES: Using a standardised diagnostic and generic treatment path for breast cancer, and the molecular subtype perspective, we aim to measure the impact of several patient and disease characteristics on the overall treatment cost for patients. Additionally, we aim to generate insights into the...

Descripción completa

Detalles Bibliográficos
Autores principales: Roman, Erin, Cardoen, Brecht, Decloedt, Jan, Roodhooft, Filip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348323/
https://www.ncbi.nlm.nih.gov/pubmed/32641325
http://dx.doi.org/10.1136/bmjopen-2019-035389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348323/
https://www.ncbi.nlm.nih.gov/pubmed/32641325
http://dx.doi.org/10.1136/bmjopen-2019-035389

Ejemplares similares